Beacon Pharmaceuticals ltd offers Xonimide under the generic of Zonasamide, an antiseizure agent which indicated as

  • Monotherapy in the treatment of partial seizures ,with or without secondary generalization, in adults with newly diagnosed epilepsy
  • Adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in adults, adolescents, and children aged 6 years and above.

Xonimide is available in capsule form with a strength of 50 mg in 30’s Alu-Alu blister pack.